Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment.

Literature DB >> 23980128

Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment.

Madeline Bilodeau¹, Stephanie Burns, John Gawoski, Samuel Moschella, Winnie Ooi.

Abstract

120 patients attending a Hansen's disease public health satellite clinic were evaluated for selected latent co-morbidities, consisting of strongyloidiasis, Chagas disease, hepatitis B, HIV, and tuberculosis, and potential exacerbation by immunosuppressive therapy. Implications for treatment of Hansen's disease are discussed.

Entities: Disease Species

Mesh：

Substances：

Year: 2013 PMID： 23980128 PMCID： PMC3795112 DOI： 10.4269/ajtmh.13-0167

Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345

Keyword Cloud
References

12 in total

Review 1. A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

Authors: Maria Ângela B Trindade; Noemia B Carvalho; Elaini C Belfort; Carla Pagliari; Erika Gakiya; Neusa Y Sakai-Valente; Gil Benard; Maria A Shikanai-Yasuda
Journal: Am J Trop Med Hyg Date: 2011-06 Impact factor: 2.345

2. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors:
Journal: MMWR Recomm Rep Date: 1997-12-26

3. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war.

Authors: L L Pelletier; C B Baker; A A Gam; T B Nutman; F A Neva
Journal: J Infect Dis Date: 1988-03 Impact factor: 5.226

4. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape.

Authors: Nora Martel; Laurent Cotte; Mary-Anne Trabaud; Christian Trepo; Fabien Zoulim; Selma A Gomes; Alan Kay
Journal: J Infect Dis Date: 2012-03-29 Impact factor: 5.226

Review 5. Parasitic central nervous system infections in immunocompromised hosts.

Authors: Melanie Walker; Joseph R Zunt
Journal: Clin Infect Dis Date: 2005-03-02 Impact factor: 9.079

Review 6. Prophylaxis and treatment of hepatitis B in immunocompromised patients.

Authors: A Marzano; E Angelucci; P Andreone; M Brunetto; R Bruno; P Burra; P Caraceni; B Daniele; V Di Marco; F Fabrizi; S Fagiuoli; P Grossi; P Lampertico; R Meliconi; A Mangia; M Puoti; G Raimondo; A Smedile
Journal: Dig Liver Dis Date: 2007-03-26 Impact factor: 4.088

Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment.

Review 1. A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

2. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC).

3. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war.

4. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape.

Review 5. Parasitic central nervous system infections in immunocompromised hosts.

Review 6. Prophylaxis and treatment of hepatitis B in immunocompromised patients.

7. Leprosy and HIV, where are we at?

Review 8. Corticosteroids for treating nerve damage in leprosy. A Cochrane review.

9. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees.

Review 10. Severe strongyloidiasis: a systematic review of case reports.